Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | DRD4 | P21917 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NQO1 | P15559 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15250532 | 0.93 | HPGD (0.49) | WDR5L3MBTL1DRD2DRD4DRD3 | |
| SCHEMBL22941843 | 0.87 | MAPT (0.45) | WDR5L3MBTL1DRD2DRD4DRD3 | |
| SCHEMBL21791988 | 0.87 | PPARA (0.47) | WDR5L3MBTL1DRD2DRD4DRD3 | |
| SCHEMBL717121 | 0.86 | NQO1 (0.47) | L3MBTL1LMNAGAAPARP10TSHR | |
| SCHEMBL15250528 | 0.84 | USP2 (0.43) | WDR5L3MBTL1DRD2DRD4DRD3 | |
| SCHEMBL15250545 | 0.84 | USP2 (0.43) | WDR5L3MBTL1DRD2DRD4DRD3 | |
| SCHEMBL15250530 | 0.82 | PPARA (0.44) | WDR5L3MBTL1DRD2DRD4DRD3 | |
| SCHEMBL15250539 | 0.82 | RELA (0.53) | WDR5MAPTHPGDMAOBNPC1 | |
| SCHEMBL15250549 | 0.82 | RELA (0.53) | WDR5MAPTHPGDMAOBNPC1 | |
| SCHEMBL15250546 | 0.82 | PPARA (0.44) | WDR5L3MBTL1DRD2DRD4DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230133211-A1 | PHOTOCHROMIC CYCLIC COMPOUND AND CURABLE COMPOSITION CONTAINING THE PHOTOCHROMIC CYCLIC COMPOUND | TOKUYAMA CORPORATION (JP) | 2023-05-04 | — | — | US | disclosed |
| CN-108567129-B | N-acyl-amino acid derivatives for improving flavor profile of edible compositions | 奇华顿股份有限公司 | 2021-10-29 | — | — | CN | disclosed |
| CN-105658086-B | Method for purifying N-acyl amino acids by using propylene glycol as extraction solvent | 奇华顿股份有限公司 | 2021-04-06 | — | — | CN | disclosed |
| CN-106659204-B | Sweetener composition | 奇华顿股份有限公司 | 2021-03-02 | — | — | CN | disclosed |
| US-20210010026-A1 | RETROVIRAL TRANSDUCTION USING POLOXAMERS | AFFINI-T THERAPEUTICS, INC. | 2021-01-14 | — | — | US | disclosed |
| CN-112074195-A | Apple vinegar nutritional supplement | 高丽营养有限公司 | 2020-12-11 | — | — | CN | disclosed |
| WO-2016201354-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | GLOBAVIR BIOSCIENCES, INC. (US) | 2016-12-15 | — | — | WO | disclosed |
| EP-2695878-B1 | Multi-functional monomer having a photocreative group, alignment film for LCD using the monomer, and LCD comprising the alignment film | LG CHEMICAL LTD (KR) | 2015-06-10 | — | — | EP | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-7892711-B2 | Azo compound, composition for photo-alignment film using the same, and method for producing photo-alignment film | DIC CORPORATION (JP) | 2011-02-22 | — | — | US | disclosed |
| US-7678445-B2 | Extruded toner receiver layer for electrophotography | EASTMAN KODAK COMPANY (US) | 2010-03-16 | — | — | US | disclosed |
| US-20090088545-A1 | Polymerziable liquid crystal compound, polymerziable liquid crystal composition comprising the same, and polymer produced using them | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-04-02 | — | — | US | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| US-20070254220-A1 | Azo Compound, Composition For Photo-Alignment Film Using The Same, And Method For Producing Photo-Alignment Film | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-11-01 | — | — | US | disclosed |
| US-20070212527-A1 | EXTRUDED TONER RECEIVER LAYER FOR ELECTROPHOTOGRAPHY | BANK OF AMERICA, N.A., AS AGENT | 2007-09-13 | — | — | US | disclosed |
| US-7264867-B2 | Extruded toner receiver layer for electrophotography | EASTMAN KODAK COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| US-7264664-B2 | Ink composition, recording method and recorded image utilizing the same, ink set and ink head | SHARP KABUSHIKI KAISHA (JP) | 2007-09-04 | — | — | US | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | WDR5 1784/4885L3MBTL1 2575/4885DRD2 409/4885 |
| US-20070254220-A1 | Azo Compound, Composition For Photo-Alignment Film Using The Same, And Method For Producing Photo-Alignment Film | CRY1, MMS19, C1R | WDR5 1066/4885L3MBTL1 2938/4885DRD2 2772/4885 |
| US-20210010026-A1 | RETROVIRAL TRANSDUCTION USING POLOXAMERS | CD44, CD74, POLI | WDR5 1491/4885L3MBTL1 3602/4885DRD2 4416/4885 |
| US-20090088545-A1 | Polymerziable liquid crystal compound, polymerziable liquid crystal composition comprising the same, and polymer produced using them | ZYX, MBD2, CRYZ | WDR5 1758/4885L3MBTL1 1101/4885DRD2 457/4885 |
| US-20230133211-A1 | PHOTOCHROMIC CYCLIC COMPOUND AND CURABLE COMPOSITION CONTAINING THE PHOTOCHROMIC CYCLIC COMPOUND | CRY1, CCNL2, CCNT1 | WDR5 583/4885L3MBTL1 2257/4885DRD2 2984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.